BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20300134)

  • 1. Quieting T cells with Slfn2.
    Horton MR; Powell JD
    Nat Immunol; 2010 Apr; 11(4):281-2. PubMed ID: 20300134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence.
    Berger M; Krebs P; Crozat K; Li X; Croker BA; Siggs OM; Popkin D; Du X; Lawson BR; Theofilopoulos AN; Xia Y; Khovananth K; Moresco EM; Satoh T; Takeuchi O; Akira S; Beutler B
    Nat Immunol; 2010 Apr; 11(4):335-43. PubMed ID: 20190759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLFN2 protection of tRNAs from stress-induced cleavage is essential for T cell-mediated immunity.
    Yue T; Zhan X; Zhang D; Jain R; Wang KW; Choi JH; Misawa T; Su L; Quan J; Hildebrand S; Xu D; Li X; Turer E; Sun L; Moresco EMY; Beutler B
    Science; 2021 May; 372(6543):. PubMed ID: 33986151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slfn2 mutation-induced loss of T-cell quiescence leads to elevated de novo sterol synthesis.
    Omar I; Rom O; Aviram M; Cohen-Daniel L; Gebre AK; Parks JS; Berger M
    Immunology; 2017 Nov; 152(3):484-493. PubMed ID: 28672048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Schlafen 2 on natural killer and T cell development from common T/natural killer progenitors.
    Ahmadi S; Veinotte LL
    Pak J Biol Sci; 2011 Nov; 14(22):1002-10. PubMed ID: 22514877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The non obese diabetic (NOD) mouse: a unique model for understanding the interaction between genetics and T cell responses.
    Ridgway WM
    Rev Endocr Metab Disord; 2003 Sep; 4(3):263-9. PubMed ID: 14501177
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of T-cell quiescence by targeting Slfn2 prevents the development and progression of T-ALL.
    Goldshtein A; Zerbib SM; Omar I; Cohen-Daniel L; Popkin D; Berger M
    Oncotarget; 2016 Jul; 7(30):46835-46847. PubMed ID: 27206675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a putative regulator of early T cell activation genes. Science. 1988. 241: 202-205.
    Shaw JP; Utz PJ; Durand DB; Toole JJ; Emmel EA; Crabtree GR
    J Immunol; 2010 Nov; 185(9):4972-5. PubMed ID: 20962265
    [No Abstract]   [Full Text] [Related]  

  • 9. T cell proliferation and homeostasis: an emerging role for the cell cycle inhibitor geminin.
    Karamitros D; Kotantaki P; Lygerou Z; Kioussis D; Taraviras S
    Crit Rev Immunol; 2011; 31(3):209-31. PubMed ID: 21740351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation.
    Zhao H; Li CC; Pardo J; Chu PC; Liao CX; Huang J; Dong JG; Zhou X; Huang Q; Huang B; Bennett MK; Molineaux SM; Lu H; Daniel-Issakani S; Payan DG; Masuda ES
    J Immunol; 2005 May; 174(9):5288-97. PubMed ID: 15843525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activation of T cells by co-stimulation].
    Abe R
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():341-6. PubMed ID: 15861679
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular events mediating T cell activation.
    Altman A; Coggeshall KM; Mustelin T
    Adv Immunol; 1990; 48():227-360. PubMed ID: 1693465
    [No Abstract]   [Full Text] [Related]  

  • 13. Vav-family proteins in T-cell signalling.
    Tybulewicz VL
    Curr Opin Immunol; 2005 Jun; 17(3):267-74. PubMed ID: 15886116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the G2A receptor fails to attenuate experimental autoimmune encephalomyelitis.
    Osmers I; Smith SS; Parks BW; Yu S; Srivastava R; Wohler JE; Barnum SR; Kabarowski JH
    J Neuroimmunol; 2009 Feb; 207(1-2):18-23. PubMed ID: 19135725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a fast and sensitive method to study transcription factor activation under endogenous conditions in primary mouse T cells applying Alpha technology.
    Thuille N; Baier G
    J Immunol Methods; 2019 Aug; 471():57-60. PubMed ID: 31128086
    [No Abstract]   [Full Text] [Related]  

  • 16. The bug in MyD88 dependency.
    van Lier RA; Lutter R
    Immunity; 2006 Oct; 25(4):527-9. PubMed ID: 17046680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell response in acquired protective immunity to Mycobacterium tuberculosis infection.
    Orme IM; Lee BY; Appelberg R; Miller ES; Chi DL; Griffin JP; Roberts AD
    Bull Int Union Tuberc Lung Dis; 1991 Mar; 66(1):7-13. PubMed ID: 1859946
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of gene expression at early stages of B-cell and T-cell differentiation.
    Fitzsimmons D; Hagman J
    Curr Opin Immunol; 1996 Apr; 8(2):166-74. PubMed ID: 8725939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from immunological, biochemical, and molecular pathways of the activation mediated by IL-2 and IL-4.
    Rebollo A; Gómez J; Martínez-A C
    Adv Immunol; 1996; 63():127-96. PubMed ID: 8787631
    [No Abstract]   [Full Text] [Related]  

  • 20. A new trigger for T cells.
    Davis MM
    Cell; 2002 Aug; 110(3):285-7. PubMed ID: 12176315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.